HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
TMO
Thermo Fisher Scientific Inc
Healthcare Diagnostics & Research · Massachusetts, USA · Reports in usd
$496.11
Market Cap: $179.07B
Market Cap
$179.07B
Enterprise Val
$218.97B
P/E Ratio
26.15
P/B Ratio
3.45
Trailing PEG (1Y)
2.32
As Of
Jun 3, 2026

Overview & Key Metrics

Reporting period: Mar 28, 2026 · Q1 2026
Book Value$51.94B
Gross Margin40.25%
Profit Margin40.25%
Return on Equity13.24%
Return on Assets6.40%
Current Ratio1.53
Debt/Equity0.83
LT Debt/Equity0.77
Revenue Per Share29.62

Income Statement

Mar 28, 2026
Revenue$11.01B
Cost of Revenue$6.58B
Gross Profit$4.43B
R&D$336.0M
SG&A$2.18B
Operating Expenses$2.57B
Operating Income$1.86B
Interest Expense$354.0M
Tax Expense$70.0M
Net Income$1.65B
EPS (Basic)$4.44
EPS (Diluted)$4.43
EBIT$2.08B
EBITDA$2.81B
Consolidated Income$1.66B
Non-Controlling Interests$5.0M

Balance Sheet

Mar 28, 2026
Cash & Equivalents$3.25B
Accounts Receivable$9.20B
Inventory$5.50B
Current Assets$22.32B
LT Investments$0.00
Property, Plant & Equipment$10.66B
Intangibles$74.33B
Non-Current Assets$90.97B
Total Assets$113.28B
Accounts Payable$3.34B
Current Debt$3.09B
Current Liabilities$14.62B
LT Debt$40.07B
Non-Current Liabilities$46.72B
Total Liabilities$61.34B
Total Debt$43.16B
Retained Earnings$60.63B
Shareholder Equity$51.93B
Shares Outstanding371,484,244

Cash Flow Statement

Mar 28, 2026
Operating Cash Flow$1.19B
Investing Cash Flow-$8.96B
Financing Cash Flow$1.09B
CapEx-$367.0M
Free Cash Flow$825.0M
Depreciation & Amort.$736.0M
Stock-Based Comp$83.0M
Acquisitions / Disposals-$8.87B
Investment Activity$236.0M
Debt Issued/Repaid$4.22B
Equity Issued/Repaid-$3.00B
Dividends Paid-$162.0M
Net Change in Cash-$6.60B
Data cached · Meta live · Daily live · Statements live · TTL 24h